BP
SGEN

Ballentine Partners’s Seagen Inc. Common Stock SGEN Stock Holding History

Ballentine Partners’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,551
Closed -$541K – 721
2023
Q3 		$541K Sell
2,551
-16
-0.6% -$3.2K 0.01% 304
2023
Q2 		$494K Buy
2,567
+23
+0.9% +$4.57K 0.01% 322
2023
Q1 		$515K Buy
2,544
+508
+25% +$81.5K 0.01% 297
2022
Q4 		$262K Buy
+2,036
New +$263K 0.01% 410

Other funds holding SGEN

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Ballentine Partners's SGEN Position: Q4 2023 in Review

Ballentine Partners sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 2,551 shares — an estimated $541K sold.

Ballentine Partners first reported a position in SGEN in Q4 2022 and held it in 4 quarters. The position peaked at $541K in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Ballentine Partners reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Ballentine Partners sold 2,551 Seagen Inc. Common Stock shares in Q4 2023, an estimated $541K.
  • Ballentine Partners first reported a position in Seagen Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • Ballentine Partners's Seagen Inc. Common Stock position peaked at $541K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Ballentine Partners's 13F filing for Q4 2023, filed 23 Jan 2024.